Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2011 | 09-2011 | 03-2011 | 03-2010 | 09-2009 | |
| Sales | 5,483,867 | 4,454,151 | 4,113,181 | 3,728,350 | 1,827 |
| Gross Profit | 5,483,867 | 4,454,151 | 4,113,181 | 3,728,350 | 1,827 |
| Operating Income | 5,483,867 | 4,454,151 | 4,113,181 | 3,728,350 | 1,827 |
| Pre-tax Income | 5,483,867 | 4,454,151 | 4,113,181 | 3,728,350 | 1,827 |
| Net Income Continuous | 321,816 | 774,980 | 393,692 | 425,703 | -1,257 |
| Net Income | $321,816 | $774,980 | $393,692 | $425,703 | $-1,257 |
| EPS Basic Total Ops | 0.20 | 0.49 | 0.25 | 0.27 | -0.21 |
| EPS Basic Continuous Ops | 0.20 | 0.49 | 0.25 | 0.27 | -0.21 |
| EPS Diluted Total Ops | 0.20 | 0.49 | 0.25 | 0.27 | -0.21 |
| EPS Diluted Continuous Ops | 0.20 | 0.49 | 0.25 | 0.27 | -0.21 |
| EBITDA(a) | $5,483,867 | $4,454,151 | $4,113,181 | $3,728,350 | $1,827 |